Authors: Capiluppi, B Ciuffreda, D Quinzan, GP Sciandra, M Marroni, M Morandini, B Costigliola, P Guerra, L Di Pietro, M Fibbia, GF Visona, R Cusini, M Bressi, C Tambussi, G Lazzarin, A

Citation: B. Capiluppi et al., Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters, J BIOL REG, 14(1), 2000, pp. 58-62

Authors: Barassi, C De Santis, C Pastori, C Marraccini, P Ciuffreda, D Capiluppi, B Bressi, C Siccardi, AG Lazzarin, A Tambussi, G Lopalco, L

Citation: C. Barassi et al., Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection, J BIOL REG, 14(1), 2000, pp. 68-74

Authors: Pareti, FI Lattuada, A Bressi, C Zanobini, M Sala, A Steffan, A Ruggeri, ZM

Citation: Fi. Pareti et al., Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis, CIRCULATION, 102(11), 2000, pp. 1290-1295

Authors: Invernizzi, G Broich, G Bressi, C Guggeri, G Caparrelli, S Deliliers, GL

Citation: G. Invernizzi et al., The organization of a counselling service for the families of patients undergoing bone marrow transplant, ANTICANC R, 19(3B), 1999, pp. 2293-2297

Authors: Meucci, G Pareti, F Vecchi, M Saibeni, S Bressi, C de Franchis, R

Citation: G. Meucci et al., Serum von Willebrand factor levels in patients with inflammatory bowel disease are related to systemic inflammation, SC J GASTR, 34(3), 1999, pp. 287-290